You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 1, July 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Liver Disease in Kidney Transplant Patients Receiving Azathioprine

Patricia Ireland, MD; Abdur Rashid, MD, FRCP (C); Franz von Lichtenberg, MD; Tito Cavallo, MD; John P. Merrill, MD

Arch Intern Med. 1973;132(1):29-37.


Abstract

The liver disease in 24 kidney transplant patients receiving azathioprine was reviewed to determine the cause and appropriate management. Azathioprine hepatotoxicity could not be implicated in any of the 24 patients, and there was no correlation between the course of the liver disease and azathioprine administration and withdrawal. Seven patients had "nonspecific reactive hepatitis" associated with sepsis and other complications; 12 patients had viral hepatitis, based on the clinical course, histopathologic and laboratory findings, and tests for Australia antigen; and in five patients the cause of the liver disease could not be determined. The high morbidity of viral hepatitis in these patients (fulminant hepatitis in one and post-necrotic cirrhosis in two) suggested an adverse effect of immunosuppression. Liver disease is not an indication to discontinue azathioprine therapy, but rather to reduce total immunosuppression whenever possible.



Author Affiliations

Boston

From the departments of medicine (Drs. Ireland, Rashid, and Merrill) and pathology (Drs. von Lichtenberg and Cavallo), Peter Bent Brigham Hospital, Boston. Dr. Ireland is presently with Bernalillo County Medical Center, Albuquerque, NM, Dr. Rashid is at Ottawa General Hospital, Ottawa, and Dr. Cavallo is at Montefiore Hospital, Pittsburgh.


Footnotes

Received for publication Feb 24, 1972; accepted May 19.

Reprint requests to Bernalillo County Medical Center, 2211 Lomas Blvd NE, Albuquerque, NM 87106 (Dr. Ireland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hepatic Veno-occlusive Disease Associated with Renal Transplantation and Azathioprine Therapy
READ et al.
ANN INTERN MED 1986;104:651-655.
ABSTRACT  

Liver Disease in Renal Transplant Recipients
Anuras et al.
Arch Intern Med 1977;137:42-48.
ABSTRACT  

Altered Reticuloendothelial Function in Long-Term Renal Allograft Recipients
Drivas et al.
Arch Surg 1976;111:1368-1371.
ABSTRACT  

Parenterally Transmitted Hepatitis A Associated with Platelet Transfusions: Epidemiologic Study of an Outbreak in a Marrow Transplantation Center
MEYERS et al.
ANN INTERN MED 1974;81:145-151.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.